Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: J Am Coll Surg. 2010 May;210(5):718–726. doi: 10.1016/j.jamcollsurg.2009.12.032

Table 3.

Multivariate Adjusted Cox Proportional Hazards of Death-Censored Graft Loss in a Single Center Study of 392 Male Recipients and 276 Female Recipients

Male Recipients Female Recipients

Variable Hazard Ratio p Value Hazard Ratio p Value
Donor age (continuous) 0.99 (0.97–1.02) NS 0.99 (0.96–1.02) NS
Recipient age (continuous) 0.98 (0.96–1.01) NS 0.97 (0.94–1.00) NS
African-American race versus non-African-
American race (donor)
0.44 (0.13–1.55) NS 0.63 (0.27–1.46) NS
African-American race versus non-
African-American race (recipient)
1.75 (0.66–4.63) NS 1.20 (0.47–3.06) NS
Hypertension (yes versus no) 1.01 (0.31–3.24) NS 2.71 (0.64–11.40) NS
Diabetes mellitus (yes versus no) 0.52 (0.15–1.85) NS 1.34 (0.57–3.15) NS
Number of HLA mismatch (continuous) 1.31 (0.99–1.75) 0.03 1.44 (1.10–1.87) 0.01
Cold ischemia time (continuous) 1.03 (0.99–1.07) NS 0.95 (0.90–0.99) 0.02
Warm ischemia time (continuous) 0.98 (0.95–1.00) NS 1.01 (0.99–1.04) NS
Peak PRA (≥50 versus <50) 1.68 (0.48–5.82) NS 0.42 (0.17–1.04) NS
Previous kidney transplant (yes versus no) 0.66 (0.18–2.48) NS 4.46 (1.43–13.8) 0.01
Donor type (deceased versus living donor) 0.60 (0.14–2.64) NS 2.67 (0.55–12.9) NS
30-day acute rejection (yes versus no) 13.5 (2.44–74.5) <0.01 1.49 (0.24–9.29) NS
Male donor BMI >2 units compared to
recipient versus others
1.86 (0.72–4.81) NS 0.19 (0.05–0.67) 0.01
Male donor versus female donor 0.91 (0.35–2.33) NS 3.45 (1.40–8.51) 0.01

HLA, human leukocyte antigen; PRA, panel-reactive lymphocytotoxic antibody.